Table 1. Baseline characteristics of... | American Society of Hematology

Table 1.

Baseline characteristics of subjects

	Arm A: rHuEPO + rHuG-CSF	Arm B: supportive care
Median age, y (range)	73 (43-80)	71 (48-89)
Sex, male/female	14/16	16/14
FAB classification
RA	9	11
RARS	15	11
RAEB, less than 10% blasts	6	8
IPSS: Low/Int1/Int2/High	12/10/1/1^*	11/13/1/1†
Hemoglobin concentration, g/L, mean ± SEM	86 ± 12	86 ± 11
Prior RBC transfusions, yes/no	30/0	26/4
Serum erythropoietin concentration, IU/L, mean ± SEM	178.8 ± 124.4	138.2 ± 132.2

	Arm A: rHuEPO + rHuG-CSF	Arm B: supportive care
Median age, y (range)	73 (43-80)	71 (48-89)
Sex, male/female	14/16	16/14
FAB classification
RA	9	11
RARS	15	11
RAEB, less than 10% blasts	6	8
IPSS: Low/Int1/Int2/High	12/10/1/1^*	11/13/1/1†
Hemoglobin concentration, g/L, mean ± SEM	86 ± 12	86 ± 11
Prior RBC transfusions, yes/no	30/0	26/4
Serum erythropoietin concentration, IU/L, mean ± SEM	178.8 ± 124.4	138.2 ± 132.2

For each arm n = 30 subjects. IPSS indicates International Prognostic Scoring System; Low, low risk; Int1, intermediate 1 risk; Int2, intermediate 2 risk; and High, high risk.

Only results concerning 24 subjects could be evaluated.

†

Only results concerning 26 subjects could be evaluated.

View Large

This Feature Is Available To Subscribers Only